iZafe Group AB (publ) (IZAFE-B.ST)
SEK 0.21
(-0.93%)
SEK 0.21
(-0.93%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.05 Million SEK | -22.24% |
| 2022 | 5.21 Million SEK | 108.44% |
| 2021 | 2.5 Million SEK | 8.55% |
| 2020 | 2.3 Million SEK | 357.85% |
| 2019 | 503 Thousand SEK | 112.38% |
| 2018 | -4.06 Million SEK | -629.62% |
| 2017 | -557 Thousand SEK | -0.54% |
| 2016 | -554 Thousand SEK | -525.32% |
| 2015 | -88.59 Thousand SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| 2011 | - SEK | 0.0% |
| 2010 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.7 Million SEK | -8.59% |
| 2024 Q2 | 4.46 Million SEK | 20.46% |
| 2024 Q3 | 4.04 Million SEK | -9.46% |
| 2023 Q2 | 5.1 Million SEK | -2.31% |
| 2023 Q4 | 4.05 Million SEK | -6.4% |
| 2023 Q3 | 4.32 Million SEK | -15.22% |
| 2023 FY | 4.05 Million SEK | -22.24% |
| 2023 Q1 | 5.22 Million SEK | 0.31% |
| 2022 Q3 | 4.65 Million SEK | 8.2% |
| 2022 FY | 5.21 Million SEK | 108.44% |
| 2022 Q1 | 3.31 Million SEK | 32.44% |
| 2022 Q2 | 4.3 Million SEK | 30.02% |
| 2022 Q4 | 5.21 Million SEK | 11.87% |
| 2021 Q1 | 2.2 Million SEK | -4.43% |
| 2021 FY | 2.5 Million SEK | 8.55% |
| 2021 Q4 | 2.5 Million SEK | -9.02% |
| 2021 Q3 | 2.74 Million SEK | 8.87% |
| 2021 Q2 | 2.52 Million SEK | 14.68% |
| 2020 Q4 | 2.3 Million SEK | -19.31% |
| 2020 Q1 | 511 Thousand SEK | 1.59% |
| 2020 Q2 | 725 Thousand SEK | 41.88% |
| 2020 Q3 | 2.85 Million SEK | 293.66% |
| 2020 FY | 2.3 Million SEK | 357.85% |
| 2019 Q3 | -1.82 Million SEK | 19.96% |
| 2019 FY | 503 Thousand SEK | 112.38% |
| 2019 Q4 | 503 Thousand SEK | 127.58% |
| 2019 Q1 | 1.00 SEK | 100.0% |
| 2019 Q2 | -2.27 Million SEK | -227900100.0% |
| 2018 Q4 | -3.4 Million SEK | -340900100.0% |
| 2018 FY | -4.06 Million SEK | -629.62% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q3 | 1.00 SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2017 FY | -557 Thousand SEK | -0.54% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q3 | -230.08 Thousand SEK | 0.0% |
| 2017 Q4 | - SEK | 100.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 FY | -554 Thousand SEK | -525.32% |
| 2016 Q1 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2015 FY | -88.59 Thousand SEK | 0.0% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2014 Q3 | - SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2014 Q2 | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2013 Q1 | - SEK | 0.0% |
| 2013 Q4 | - SEK | 0.0% |
| 2013 Q3 | - SEK | 0.0% |
| 2013 Q2 | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| 2012 Q3 | - SEK | 0.0% |
| 2012 Q4 | - SEK | 0.0% |
| 2011 FY | - SEK | 0.0% |
| 2010 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AddLife AB (publ) | 1.65 Billion SEK | 99.755% |
| Biotage AB (publ) | 437 Million SEK | 99.073% |
| Bonesupport Holding AB (publ) | 83.3 Million SEK | 95.136% |
| Doxa AB (publ) | - SEK | -Infinity% |
| Elekta AB (publ) | 3.25 Billion SEK | 99.876% |
| Ortivus AB (publ) | 12.45 Million SEK | 67.477% |
| Ortivus AB (publ) | 12.45 Million SEK | 67.477% |
| Q-linea AB (publ) | 46.52 Million SEK | 91.291% |
| S2Medical AB (publ) | 4.09 Million SEK | 1.164% |
| Synsam AB (publ) | 707 Million SEK | 99.427% |